Brief: Vera Therapeutics Q3 EPS USD -0.85 Vs. IBES Estimate USD -0.66
07/11/2024 13:00
Nov 07 (Reuters) - Vera Therapeutics Q3 operating income USD -49.801 million vs. IBES estimate USD -37.3 million. * Q3 net income USD -46.632 million vs. IBES estimate USD -36.9 million * Q3 operating expenses USD 49.801 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial